Tayla Rose Assistant Clinical Professor, Department of Pharmacy and Health Systems Sciences t.rose@northeastern.edu 617.373.3189 Expertise ambulatory care, elderly care, health systems, pharmaceutical sciences Tayla Rose for Northeastern Global News EpiPen’s pricing debacle and its impact on patients, insurers EpiPen’s pricing debacle and its impact on patients, insurers A firestorm erupted this week in response to the pharmaceutical company Mylan’s sharp increase in the price of its EpiPen, a life-saving treatment for severe allergic reactions. The company quickly backtracked, announcing a rebate plan. Here, three Northeastern faculty members—pharmacist Tayla Rose, healthcare finance expert Steven Pizer, and health policy researcher Gary Young—explain the clinical, economic, and policy implications of the controversy.